Product Code: ETC4538020 | Publication Date: Jul 2023 | Updated Date: Aug 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 | |
Human Milk Oligosaccharides (HMOs) are gaining prominence as functional ingredients in infant formula and food products. The Saudi Arabia HMO market provides these naturally occurring sugars, which offer health benefits, particularly for infant nutrition.
The HMO market is expanding as consumers and the infant formula industry seek alternatives to breast milk. HMOs are essential for developing infant formulas and supplements that mimic the nutritional benefits of breast milk, supporting infant nutrition and health.
The HMO market in Saudi Arabia faces challenges related to the development and use of human milk oligosaccharides as functional ingredients, addressing HMO sourcing, bioactivity, and formulation compatibility, and ensuring the successful incorporation of HMO in infant nutrition and other products.
The Human Milk Oligosaccharides (HMO) market in Saudi Arabia, essential for infant nutrition and gut health, faced challenges during the pandemic, including supply chain disruptions and shifting health priorities. However, as infant nutrition and functional foods continue to evolve, the market is showing signs of revival.
Human milk oligosaccharides (HMOs) are gaining attention for their potential health benefits. In Saudi Arabia, key players like DuPont Nutrition & Biosciences, Nestl? Health Science, and Glycom are significant in the HMO market. They provide HMO-based products for infant formula and nutritional applications.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Saudi Arabia Human Milk Oligosaccharides (HMO) Market Overview |
3.1 Saudi Arabia Country Macro Economic Indicators |
3.2 Saudi Arabia Human Milk Oligosaccharides (HMO) Market Revenues & Volume, 2021 & 2031F |
3.3 Saudi Arabia Human Milk Oligosaccharides (HMO) Market - Industry Life Cycle |
3.4 Saudi Arabia Human Milk Oligosaccharides (HMO) Market - Porter's Five Forces |
3.5 Saudi Arabia Human Milk Oligosaccharides (HMO) Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Saudi Arabia Human Milk Oligosaccharides (HMO) Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Saudi Arabia Human Milk Oligosaccharides (HMO) Market Revenues & Volume Share, By Concentration, 2021 & 2031F |
4 Saudi Arabia Human Milk Oligosaccharides (HMO) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the benefits of human milk oligosaccharides (HMOs) for infant health |
4.2.2 Growing demand for infant formula with added HMOs as a result of rising disposable income |
4.2.3 Focus on research and development to enhance the efficacy of HMO-based products |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for HMO products in Saudi Arabia |
4.3.2 Limited availability of HMO-enriched products in the market due to production challenges |
5 Saudi Arabia Human Milk Oligosaccharides (HMO) Market Trends |
6 Saudi Arabia Human Milk Oligosaccharides (HMO) Market, By Types |
6.1 Saudi Arabia Human Milk Oligosaccharides (HMO) Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Saudi Arabia Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Type, 2021-2031F |
6.1.3 Saudi Arabia Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 2?? Fl, 2021-2031F |
6.1.4 Saudi Arabia Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 3?? Fl, 2021-2031F |
6.1.5 Saudi Arabia Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 3?? Sl, 2021-2031F |
6.1.6 Saudi Arabia Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 6?? Sl, 2021-2031F |
6.2 Saudi Arabia Human Milk Oligosaccharides (HMO) Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Saudi Arabia Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Infant Formula, 2021-2031F |
6.2.3 Saudi Arabia Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Functional Food & Beverages, 2021-2031F |
6.2.4 Saudi Arabia Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Food Supplement, 2021-2031F |
6.3 Saudi Arabia Human Milk Oligosaccharides (HMO) Market, By Concentration |
6.3.1 Overview and Analysis |
6.3.2 Saudi Arabia Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Neutral, 2021-2031F |
6.3.3 Saudi Arabia Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Acidic, 2021-2031F |
7 Saudi Arabia Human Milk Oligosaccharides (HMO) Market Import-Export Trade Statistics |
7.1 Saudi Arabia Human Milk Oligosaccharides (HMO) Market Export to Major Countries |
7.2 Saudi Arabia Human Milk Oligosaccharides (HMO) Market Imports from Major Countries |
8 Saudi Arabia Human Milk Oligosaccharides (HMO) Market Key Performance Indicators |
8.1 Research and development investment in HMO technology |
8.2 Number of clinical trials and studies on the benefits of HMOs for infant health |
8.3 Adoption rate of HMO-enriched infant formula by Saudi Arabian consumers |
9 Saudi Arabia Human Milk Oligosaccharides (HMO) Market - Opportunity Assessment |
9.1 Saudi Arabia Human Milk Oligosaccharides (HMO) Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Saudi Arabia Human Milk Oligosaccharides (HMO) Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Saudi Arabia Human Milk Oligosaccharides (HMO) Market Opportunity Assessment, By Concentration, 2021 & 2031F |
10 Saudi Arabia Human Milk Oligosaccharides (HMO) Market - Competitive Landscape |
10.1 Saudi Arabia Human Milk Oligosaccharides (HMO) Market Revenue Share, By Companies, 2024 |
10.2 Saudi Arabia Human Milk Oligosaccharides (HMO) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |